News & Trends

• 212025-11

  Salubris’ Innovative Small Molecule Drug SAL0139 Receives Approval to Enter Clinical Trials for the Treatment of Hyperlipidemia

• 212025-10

  Breakthrough in Clinical Trials of Innovative Anti-Cancer Drug JK06 Shows Potential in Treating Advanced Solid Tumors

• 152025-10

  Breaking News: Salubris' SAL0137 Clinical Trial Application Accepted for Treatment of Elevated Lipoprotein(a)

• 302025-09

  Breaking News: Salubris Achieves Phase Progress in Two Independently Innovated Biologic Drugs

• 292025-09

  Latest! Salubris' SAL0140 New Indication Clinical Trial Application Accepted, Potential Breakthrough in Hypertension Treatment

• 192025-09

  Salubris' Class 1 Biological Drug Ticalicibart Injection Marketing Application Accepted